Viewing Study NCT05908734


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2025-12-30 @ 11:46 AM
Study NCT ID: NCT05908734
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-19
First Post: 2023-06-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung Cancer
Sponsor: Janssen Research & Development, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module